I think you may be right , perhaps they have the imminent news of Nasdaq move and will be announced We have our three analysts formulating the STRONG BUY rating HGEN$$$$
Very well organized call. The operator went out of her way to make HGEN come across as very regal. It was a lot of info rehashing and they were careful of not setting future dates or building investor expectations. Definitely trying to impress some market makers.
HGEN had to be courting Wells Fargo, Cantor and Roth Capital. I feel those questions were already in the cue before the presentation was even finished.
If you want to be selected to ask a question next time, say your VP of Emerging BioTech from Merill Lynch... instead of Private Investor.